Trial Profile
Cytarabine + gemtuzumab ozogamicin versus cytarabine + daunorubicin in older patients with acute myeloid leukaemia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Sep 2011
Price :
$35
*
At a glance
- Drugs Gemtuzumab ozogamicin (Primary) ; Cytarabine; Daunorubicin
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 02 Aug 2011 Results published in Annals of Oncology.
- 21 Feb 2011 New trial record